321 related articles for article (PubMed ID: 24385236)
1. Efficacy and safety of ETC-1002, a novel investigational low-density lipoprotein-cholesterol-lowering therapy for the treatment of patients with hypercholesterolemia and type 2 diabetes mellitus.
Gutierrez MJ; Rosenberg NL; Macdougall DE; Hanselman JC; Margulies JR; Strange P; Milad MA; McBride SJ; Newton RS
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):676-83. PubMed ID: 24385236
[TBL] [Abstract][Full Text] [Related]
2. Targeting low-density lipoprotein and dysmetabolism in type 2 diabetes mellitus.
Goldberg R
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):477-8. PubMed ID: 24554605
[No Abstract] [Full Text] [Related]
3. Efficacy and safety of bempedoic acid in patients with and without metabolic syndrome: Pooled analysis of data from four phase 3 clinical trials.
Shapiro MD; Taub PR; Louie MJ; Lei L; Ballantyne CM
Atherosclerosis; 2023 Aug; 378():117182. PubMed ID: 37517922
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: analysis of pooled patient-level data from phase 3 clinical trials.
Duell PB; Banach M; Catapano AL; Laufs U; Mancini GBJ; Ray KK; Broestl C; Zhang Y; Lei L; Goldberg AC
J Clin Lipidol; 2024; 18(2):e153-e165. PubMed ID: 38341323
[TBL] [Abstract][Full Text] [Related]
5. Effect of Multifactorial Treatment Targets and Relative Importance of Hemoglobin A1c, Blood Pressure, and Low-Density Lipoprotein-Cholesterol on Cardiovascular Diseases in Chinese Primary Care Patients With Type 2 Diabetes Mellitus: A Population-Based Retrospective Cohort Study.
Wan EYF; Fung CSC; Yu EYT; Chin WY; Fong DYT; Chan AKC; Lam CLK
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862945
[TBL] [Abstract][Full Text] [Related]
6. LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia.
Magno S; Ceccarini G; Pelosini C; Jaccheri R; Vitti J; Fierabracci P; Salvetti G; Airoldi G; Minale M; Saponati G; Santini F
Lipids Health Dis; 2018 May; 17(1):124. PubMed ID: 29793488
[TBL] [Abstract][Full Text] [Related]
7. Bempedoic Acid for Heterozygous Familial Hypercholesterolemia: From Bench to Bedside.
Agarwala A; Quispe R; Goldberg AC; Michos ED
Drug Des Devel Ther; 2021; 15():1955-1963. PubMed ID: 34007155
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the efficacy and safety of bempedoic acid in women and men: Pooled analyses from phase 3 trials.
Goldberg AC; Banach M; Catapano AL; Duell PB; Leiter LA; Hanselman JC; Lei L; Mancini GBJ
Atherosclerosis; 2023 Nov; 384():117192. PubMed ID: 37648637
[TBL] [Abstract][Full Text] [Related]
9. Longer-Term Efficacy and Safety of Evinacumab in Patients With Refractory Hypercholesterolemia.
Rosenson RS; Burgess LJ; Ebenbichler CF; Baum SJ; Stroes ESG; Ali S; Khilla N; McGinniss J; Gaudet D; Pordy R
JAMA Cardiol; 2023 Nov; 8(11):1070-1076. PubMed ID: 37703006
[TBL] [Abstract][Full Text] [Related]
10. Understanding disparities in lipid management among patients with type 2 diabetes: gender differences in medication nonadherence after treatment intensification.
Billimek J; Malik S; Sorkin DH; Schmalbach P; Ngo-Metzger Q; Greenfield S; Kaplan SH
Womens Health Issues; 2015; 25(1):6-12. PubMed ID: 25442365
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Safety and Efficacy of Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from the CLEAR Harmony Open-Label Extension Study).
Ballantyne CM; Banach M; Bays HE; Catapano AL; Laufs U; Stroes ESG; Robinson P; Lei L; Ray KK
Am J Cardiol; 2022 Jul; 174():1-11. PubMed ID: 35483979
[TBL] [Abstract][Full Text] [Related]
12. Red yeast rice lowers cholesterol in physicians - a double blind, placebo controlled randomized trial.
Verhoeven V; Lopez Hartmann M; Remmen R; Wens J; Apers S; Van Royen P
BMC Complement Altern Med; 2013 Jul; 13():178. PubMed ID: 23866314
[TBL] [Abstract][Full Text] [Related]
13. Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin).
Pagidipati NJ; Navar AM; Pieper KS; Green JB; Bethel MA; Armstrong PW; Josse RG; McGuire DK; Lokhnygina Y; Cornel JH; Halvorsen S; Strandberg TE; Delibasi T; Holman RR; Peterson ED;
Circulation; 2017 Sep; 136(13):1193-1203. PubMed ID: 28626088
[TBL] [Abstract][Full Text] [Related]
14. Effect of Berberine on Cardiovascular Disease Risk Factors: A Mechanistic Randomized Controlled Trial.
Zhao JV; Yeung WF; Chan YH; Vackova D; Leung JYY; Ip DKM; Zhao J; Ho WK; Tse HF; Schooling CM
Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444711
[TBL] [Abstract][Full Text] [Related]
15. Bile Acid Sequestrants for Hypercholesterolemia Treatment Using Sustainable Biopolymers: Recent Advances and Future Perspectives.
Islam MS; Sharif A; Kwan N; Tam KC
Mol Pharm; 2022 May; 19(5):1248-1272. PubMed ID: 35333534
[TBL] [Abstract][Full Text] [Related]
16. Safety of bempedoic acid in patients at high cardiovascular risk and with statin intolerance.
Bays HE; Bloedon LT; Lin G; Powell HA; Louie MJ; Nicholls SJ; Lincoff AM; Nissen SE
J Clin Lipidol; 2024; 18(1):e59-e69. PubMed ID: 37951797
[TBL] [Abstract][Full Text] [Related]
17. Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: A post hoc analysis of efficacy and glycaemic control using pooled data from phase 3 clinical trials.
Leiter LA; Banach M; Catapano AL; Duell PB; Gotto AM; Laufs U; Mancini GBJ; Ray KK; Hanselman JC; Ye Z; Bays HE
Diabetes Obes Metab; 2022 May; 24(5):868-880. PubMed ID: 34981622
[TBL] [Abstract][Full Text] [Related]
18. Effects of bempedoic acid on CRP, IL-6, fibrinogen and lipoprotein(a) in patients with residual inflammatory risk: A secondary analysis of the CLEAR harmony trial.
Ridker PM; Lei L; Ray KK; Ballantyne CM; Bradwin G; Rifai N
J Clin Lipidol; 2023; 17(2):297-302. PubMed ID: 36813656
[TBL] [Abstract][Full Text] [Related]
19. Real-world utilization of bempedoic acid in an academic preventive cardiology practice.
Warden BA; Cardiology BA; Purnell JQ; Duell PB; Fazio S
J Clin Lipidol; 2022; 16(1):94-103. PubMed ID: 34924351
[TBL] [Abstract][Full Text] [Related]
20. Vigorous exercise and diabetic, hypertensive, and hypercholesterolemia medication use.
Williams PT; Franklin B
Med Sci Sports Exerc; 2007 Nov; 39(11):1933-41. PubMed ID: 17986900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
